跳至主要内容
临床试验/NCT02247934
NCT02247934已完成不适用

Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)

Gilead Sciences5 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2014年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
26
试验地点
5
主要终点
List Primary Sclerosing Cholangitis (PSC) Symptoms for inclusion in patient questionnaire

研究概览

简要总结

The objectives of this qualitative study are to elicit concepts about symptoms that are important to patients with primary sclerosing cholangitis (PSC), as well as the key impacts of symptoms on patients' day-to-day functioning.

详细描述

In Step I, concept elicitation one-on-one interviews (via telephone or in person) will be conducted. The aims of the concept elicitation interviews are to:

  1. Identify the most common symptoms, as well as the most important symptoms, for patients with PSC, and
  2. Assess whether these symptoms impact day-to-day functioning

An instrument will be developed based on the symptoms reported and in Step II of the study, the performance of the instrument will be assessed with further interviews.

研究设计

研究类型
Observational
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed diagnosis of PSC based on liver biopsy or diagnostic imaging, with diagnosis made at least three months prior to screening
  • Patient report of PSC symptoms associated with PSC diagnosis
  • Able to speak, read, and understand English
  • Willing and able to provide written informed consent to participate in the research study

排除标准

  • Patients with other causes of liver or biliary disease, including viral hepatitis, alcoholic liver disease, primary biliary cirrhosis, and secondary sclerosing cholangitis
  • Patient with history of liver cirrhosis
  • Patients with history of cholangiocarcinoma
  • Patients who have received a liver transplant
  • Patients currently enrolled in PSC clinical trials; and
  • STEP II ONLY: Enrolled in or participated in Step I of this study (concept elicitation)

结局指标

主要结局

List Primary Sclerosing Cholangitis (PSC) Symptoms for inclusion in patient questionnaire

时间窗: Up to 12 months

Interview participants to generate a list of the most common symptoms, as well as the most important symptoms, experienced by patients with PSC, and whether each symptom impacts day-to-day functioning.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验